Novo Nordisk A/S
Stocks making the biggest moves premarket: Bumble, Hims & Hers Health, Blue Owl, Netskope & more
Check out the companies making headlines before the bell. Bumble — Bumble shares popped about 21% after the dating app reported strong adjusted EBITDA and revenue results for its fourth quarter. Its first-quarter adjusted EBITDA guidance also beat analyst consensus expectations, per FactSet. Netskope — Shares of the security and networking company plunged 17% on […]
Read More
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more
Check out some of the companies making the biggest midday moves: Oil stocks – Oil stocks briefly traded higher as the commodity surged as the Iran War showed no sign of abating. U.S. crude briefly topped $110 per barrel overnight, hitting levels not seen since mid-2022. Chevron earlier hit an all-time high, Talos Energy at […]
Read More
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs
Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo’s branded medicines through its platform. “We have decided to drop the current court proceedings and, of course, we reserve to bring that back if need be, but I don’t foresee […]
Read More
Stocks making the biggest moves premarket: Hims & Hers Health, oil stocks, Live Nation Entertainment & more
Check out the companies making headlines before the bell. Oil stocks – Oil stocks traded higher as the commodity surged due to the ongoing Iran War. U.S. crude briefly topped $110 per barrel overnight, hitting levels not seen since mid-2022. Talos Energy rose 5%, while Northern Oil and Gas and ConocoPhillips gained 3% and 2%, […]
Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]
Read More
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting a major barrier to access for patients. Lilly and its chief rival, Novo Nordisk, have moved to slash the cash prices of their popular obesity injections for those who want to pay entirely out-of-pocket. But […]
Read More
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capacities to make the newly launched Wegovy pill, the Danish drugmaker said Monday. The news comes about two months after Novo launched its blockbuster weight loss drug Wegovy in pill form in the U.S. market, in […]
Read More
Here’s an update on our 4th Industrial Revolution stocks and the rest of the portfolio
On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran through each stock in the portfolio. Jim put a special focus on the Club stocks within the artificial intelligence trade. He’s dubbed them the “Fourth Industrial Revolution stocks,” borrowing the term from Nvidia CEO Jensen […]
Read More
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. Pricing pressure, fierce competition, and pipeline setbacks have […]
Read More
European stocks set for higher open as market nerves ease
The City of London skyline at sunset. Gary Yeowell | Digitalvision | Getty Images LONDON — European stocks are expected to open broadly higher on Wednesday as global market nerves eased after U.S. President Donald Trump’s universal 10% tariff came into effect rather than the threatened higher 15% rate. The U.K.’s FTSE index is seen […]
Read More